Biosimilar medicines authorized by the AEMPS
122 authorized medicines
27 active principles
Menu
- All
- Adalimumab
- aflibercept
- Bevacizumab
- Denosumab
- eculizumab
- Enoxaparin Sodium
- epoetin alfa
- Epoetin Zeta
- etanercept
- filgrastim
- follitropin alfa
- golimumab
- Infliximab
- insulin aspart
- Insulin glargine
- insulin lispro
- natalizumab
- Omalizumab
- Pegfilgrastim
- pertuzumab
- ranibizumab
- rituximab
- Somatropin
- teriparatide
- Tocilizumab
- Trastuzumab
- Believable
Tocilizumab STADA (formerly Tofidence)®
Tocilizumab STADA (formerly Tofidence)®
ACTIVE PRINCIPLE:
Tocilizumab
DATE:
26/06/2024
Enoxaparin Ledraxen®
Enoxaparin Ledraxen®
ACTIVE PRINCIPLE:
Enoxaparin Sodium
DATE:
08/08/2019
Abasaglar® (formerly Abasria®)
Abasaglar® (formerly Abasria®)
ACTIVE PRINCIPLE:
Insulin glargine
DATE:
23/06/2016